Cannabidiol Modulates Glutamate Learning Response
Clinical Takeaway A single dose of CBD in people at clinical high risk for psychosis reduced the abnormal connection between high hippocampal glutamate levels and irregular brain activity during memory tasks. This finding suggests CBD may work by…
endocannabinoid system clinical research: CBD & psychosis
Clinical Takeaway In a study of individuals at clinical high risk for psychosis, a single dose of CBD influenced the relationship between hippocampal glutamate levels and prefrontal brain activity during verbal memory tasks. This suggests CBD may work by…
Cannabinoid Clinical Trials: CBD, Psychosis Risk & Brain
Clinical Takeaway In a small study of individuals at clinical high risk for psychosis, a single dose of CBD was found to influence the relationship between hippocampal glutamate levels and prefrontal brain activation during verbal memory tasks. This…
